Luciferase Reporter Cell Line - MKN7

MKN7 is a well-characterized human gastric adenocarcinoma cell line originally isolated from a moderately to well-differentiated tubular adenocarcinoma of the stomach in a 39-year-old Japanese male patient. Growing as adherent, epithelial-like monolayers, MKN7 cells exhibit strong intestinal differentiation markers, including clear cell polarity and the presence of microvilli. The Luciferase Reporter Cell Line - MKN7 builds upon this widely utilized model by incorporating a stably integrated firefly luciferase gene into the cellular genome. This precise engineering allows the cells to constitutively express luciferase, generating a easily quantifiable bioluminescent signal when exposed to a luciferin substrate. Crucially, the introduction of the reporter gene preserves the fundamental biological properties, morphology, and genetic profile—including common tumor suppressor mutations like TP53—of the parental gastric cancer cells, ensuring that experimental models remain biologically accurate and clinically relevant.

This modified reporter cell line plays a critical role in both benchtop assays and complex animal studies targeting gastrointestinal cancers. In standard in vitro environments, the MKN7 luciferase line provides an effective platform for real-time promoter activity monitoring, high-throughput drug response analysis, and direct cytotoxicity testing. Because the bioluminescent output correlates strongly with cellular metabolic activity and viability, researchers can measure cell proliferation and exact chemotherapeutic responses with high sensitivity. Beyond standard plate assays, these cells are exceptionally valuable for preclinical in vivo research. When implanted into immunodeficient hosts, such as nude mice, to create xenograft models, the continuous light emission permits non-invasive, longitudinal small-animal imaging. This capability allows scientists to visually track tumor engraftment, dynamically monitor the timeline of gastric tumor progression, and evaluate targeted therapeutic strategies in live animals over extended periods without the need for repeated specimen sacrifices.